Hydroance

For Optimal Delivery of Poorly Permeable Drugs with Poor Absorption Potential

Hydrophilic therapeutic agents exhibit poor membrane transport properties and present enormous challenges in drug delivery primarily due to their charge, size, and stability characteristics. In absence of appreciable oral absorption, most current hydrophilic drugs must be delivered invasively.

Hydroance, Lipocine's lipid-based proprietary technology platform offers non-invasive delivery solutions for small polar organics and macromolecules. Hydroance customizes lipid based carriers for the optimal presentation of the drug and absorption promoters to the absorption site, thus enabling absorption of the drug across the epithelial cell membranes of the intestinal tract.

Hydroance is a wide range of proprietary compositions of bioacceptable absorption promoters and lipid excipients that enable oral delivery of poorly absorbed, highly water soluble drugs. Hydroance technology uses conventional manufacturing processes that are easy to scale-up and commercialize, thus reducing time to market.

Hydroance enables oral delivery of compounds that are currently delivered only by the invasive route, such as small polar organics, peptides, polysaccharides, small peptides, peptido-mimetics and potentially vaccines.

Consider LipidScreen for your target compound.